Premium
P4‐351: Evaluation of TAU Burden in a Cross‐Sectional Cohort of Alzheimer’S Disease Subjects Using [ 18 F]GTP1 (GENENTECH TAU PROBE 1)
Author(s) -
Bohorquez Sandra Sanabria,
Barret Olivier,
Tamagnan Gilles,
Alagille David,
Marik Jan,
Ayalon Gai,
Bengtsson Thomas,
Crespigny Alex,
Jennings Danna,
Seibyl John P.,
Marek Kenneth,
Weimer Robby,
Kerchner Geoffrey A.
Publication year - 2016
Publication title -
alzheimer's and dementia
Language(s) - Romanian
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2016.07.096
Subject(s) - cohort , alzheimer's disease , medicine , psychology , pittsburgh compound b , disease , oncology , nuclear medicine , pathology
P4-351 EVALUATION OF TAU BURDEN IN A CROSSSECTIONALCOHORTOFALZHEIMER’SDISEASE SUBJECTS USING [F]GTP1 (GENENTECH TAU PROBE 1) Sandra Sanabria Bohorquez, Olivier Barret, Gilles Tamagnan, David Alagille, Jan Marik, Gai Ayalon, Thomas Bengtsson, Alex de Crespigny, Danna Jennings, John P. Seibyl, Kenneth Marek, Robby Weimer, Geoffrey A. Kerchner, Genentech, Inc., South San Francicso, CA, USA; Molecular Neuroimaging, LLC, New Haven, CT, USA; 3 Genentech, Inc., South San Francisco, CA, USA. Contact e-mail: sanabris@gene.com